Users Online: 360 | Home Print this page Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

REVIEW ARTICLE

Recent trends in vaccine delivery systems: A review

Saroja C H, Lakshmi P K, Bhaskaran Shyamala

Year : 2011| Volume: 1| Issue : 2 | Page no: 64-74

   This article has been cited by
 
1 CD200 modulates macrophage cytokine secretion and phagocytosis in response to poly(lactic-co-glycolic acid) microparticles and films
Esther Y. Chen,Shu-Hui Chu,Lanny Gov,Yoon Kyung Kim,Melissa B. Lodoen,Andrea J. Tenner,Wendy F. Liu
J. Mater. Chem. B. 2017; 5(8): 1574
[Pubmed]  [Google Scholar] [DOI]
2 An Overview of Novel Adjuvants Designed for Improving Vaccine Efficacy
Srinivasa Reddy Bonam,Charalambos D. Partidos,Sampath Kumar M. Halmuthur,Sylviane Muller
Trends in Pharmacological Sciences. 2017;
[Pubmed]  [Google Scholar] [DOI]
3 Polymeric nanoparticles: Promising platform for drug delivery
Khalid M. El-Say,Hossam S. El-Sawy
International Journal of Pharmaceutics. 2017; 528(1-2): 675
[Pubmed]  [Google Scholar] [DOI]
4 Delivery of immunoreactive antigen using a controllable needle-free jet injector
N. Catherine Hogan,Melis N. Anahtar,Andrew J. Taberner,Ian W. Hunter
Journal of Controlled Release. 2017; 258: 73
[Pubmed]  [Google Scholar] [DOI]
5 Advances Towards Painless Vaccination and Newer Modes of Vaccine Delivery
Neha Garg,Anju Aggarwal
The Indian Journal of Pediatrics. 2017;
[Pubmed]  [Google Scholar] [DOI]
6 Macrophage-derived insulin-like growth factor-1 affects influenza vaccine efficacy through the regulation of immune cell homeostasis
Il-Sub Yoon,Hyelim Park,Hye-Won Kwak,Yong Woo Jung,Jae-Hwan Nam
Vaccine. 2017; 35(36): 4687
[Pubmed]  [Google Scholar] [DOI]
7 Design and characterization of plasmids encoding antigenic peptides of Aha1 from Aeromonas hydrophila as prospective fish vaccines
Pradipta R. Rauta,Bismita Nayak,Gabriel A. Monteiro,Marília Mateus
Journal of Biotechnology. 2017; 241: 116
[Pubmed]  [Google Scholar] [DOI]
8 Lactic acid bacteria - promising vaccine vectors: possibilities, limitations, doubts
K. Szatraj,A.K. Szczepankowska,M. Chmielewska-Jeznach
Journal of Applied Microbiology. 2017;
[Pubmed]  [Google Scholar] [DOI]
9 Lysozyme binding ability toward psychoactive stimulant drugs: Modulatory effect of colloidal metal nanoparticles
Vikash K. Sonu,Mullah Muhaiminul Islam,Mostofa Ataur Rohman,Sivaprasad Mitra
Colloids and Surfaces B: Biointerfaces. 2016; 146: 514
[Pubmed]  [Google Scholar] [DOI]
10 Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?
Sharan Bobbala,Sarah Hook
Pharmaceutical Research. 2016;
[Pubmed]  [Google Scholar] [DOI]
11 Overcoming formulation challenges for the next generation of vaccines
Cory Berkland,C. Russell Middaugh
Expert Opinion on Drug Delivery. 2016; 13(11): 1501
[Pubmed]  [Google Scholar] [DOI]
12 Particle size and traffic of phagocytes between the turbot peritoneal cavity and lymphoid organs
I. Folgueira,M. Noia,V. Blanco-Abad,N. Mallo,J. Leiro,J. Lamas
Fish & Shellfish Immunology. 2015; 44(2): 652
[Pubmed]  [Google Scholar] [DOI]
13 Enhancing Vaccine Safety Capacity Globally
Robert T. Chen,Tom T. Shimabukuro,David B. Martin,Patrick L.F. Zuber,Daniel M. Weibel,Miriam Sturkenboom
American Journal of Preventive Medicine. 2015; 49(6): S364
[Pubmed]  [Google Scholar] [DOI]
14 Enhancing vaccine safety capacity globally: A lifecycle perspective
Robert T. Chen,Tom T. Shimabukuro,David B. Martin,Patrick L.F. Zuber,Daniel M. Weibel,Miriam Sturkenboom
Vaccine. 2015; 33: D46
[Pubmed]  [Google Scholar] [DOI]
15 Phase 1 clinical study with Bioneedles, a delivery platform for biopharmaceuticals
Gijsbertus G.P. van de Wijdeven,Hoang J.H.B. Hirschberg,Wolfgang Weyers,Wolfgang Schalla
European Journal of Pharmaceutics and Biopharmaceutics. 2015; 89: 126
[Pubmed]  [Google Scholar] [DOI]
16 The reoccurrence of H5N1 outbreaks necessitates the development of safe and effective influenza vaccine technologies for the prevention and control of avian influenza in Sub-Saharan Africa
Yakubu Bitrus,J Nok Andrew,O A Owolodun,P D Luka,Dunkura Ali Umaru
Biotechnology and Molecular Biology Reviews. 2015; 10(3): 19
[Pubmed]  [Google Scholar] [DOI]
17 Engineered nanoparticles interacting with cells: size matters
Li Shang,Karin Nienhaus,Gerd Nienhaus
Journal of Nanobiotechnology. 2014; 12(1): 5
[Pubmed]  [Google Scholar] [DOI]
18 Construction and evaluation of replication-defective recombinant optimized triosephosphate isomerase adenoviral vaccination in Schistosoma japonicum challenged mice
Yang Dai,Xiaoting Wang,Song Zhao,Jianxia Tang,Lu Zhang,Jianrong Dai,Mingtao Zeng,Shan Lu,Yinchang Zhu,Chuan Su
Vaccine. 2014;
[Pubmed]  [Google Scholar] [DOI]
19 Polymeric nanoparticles: Potent vectors for vaccine delivery targeting cancer and infectious diseases
Azam Bolhassani,Shabnam Javanzad,Tayebeh Saleh,Mehrdad Hashemi,Mohammad Reza Aghasadeghi,Seyed Mehdi Sadat
Human vaccines & immunotherapeutics. 2014; 10(2)
[Pubmed]  [Google Scholar] [DOI]
20 Nodavirus-based biological container for targeted delivery system
Pitchanee Jariyapong
Artificial Cells, Nanomedicine, and Biotechnology. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
21 An overview of adjuvant formulations and delivery systems
Alexis García,Juan B. De Sanctis
APMIS. 2013; : n/a
[Pubmed]  [Google Scholar] [DOI]
22 Encapsulation and delivery of plasmid DNA by virus-like nanoparticles engineered from Macrobrachium rosenbergii nodavirus
Pitchanee Jariyapong,Charoonroj Chotwiwatthanakun,Monsicha Somrit,Sarawut Jitrapakdee,Li Xing,Holland R. Cheng,Wattana Weerachatyanukul
Virus Research. 2013;
[Pubmed]  [Google Scholar] [DOI]
23 Development of a nanoparticle-based influenza vaccine using the PRINT® technology
Ashley L. Galloway,Andrew Murphy,Joseph M. DeSimone,Jie Di,Jennifer P. Herrmann,Michael E. Hunter,Jeffrey P. Kindig,Frank J. Malinoski,Megan A. Rumley,Daria M. Stoltz,Thomas S. Templeman,Bolyn Hubby
Nanomedicine: Nanotechnology, Biology and Medicine. 2013; 9(4): 523
[Pubmed]  [Google Scholar] [DOI]

 

Read this article